Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Return on Capital Employed (2016 - 2025)

Aethlon Medical filings provide 14 years of Return on Capital Employed readings, the most recent being 185.23% for Q1 2025.

  • On a quarterly basis, Return on Capital Employed fell 1700.0% to 185.23% in Q1 2025 year-over-year; TTM through Mar 2025 was 185.23%, a 1700.0% decrease, with the full-year FY2025 number at 158.24%, down 4385.0% from a year prior.
  • Return on Capital Employed hit 185.23% in Q1 2025 for Aethlon Medical, down from 166.15% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 36.89% in Q3 2021 to a low of 185.23% in Q1 2025.
  • Median Return on Capital Employed over the past 5 years was 76.65% (2021), compared with a mean of 98.05%.
  • Biggest five-year swings in Return on Capital Employed: surged 2135bps in 2022 and later tumbled -10067bps in 2024.
  • Aethlon Medical's Return on Capital Employed stood at 40.78% in 2021, then tumbled by -67bps to 67.9% in 2022, then plummeted by -95bps to 132.49% in 2023, then fell by -25bps to 166.15% in 2024, then fell by -11bps to 185.23% in 2025.
  • The last three reported values for Return on Capital Employed were 185.23% (Q1 2025), 166.15% (Q4 2024), and 148.41% (Q3 2024) per Business Quant data.